Too many—or too few—pounds—could be a factor in migraine pathogenesis. Details here.
Just how private is that information your patient records in a mobile headache diary?
Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.
If you are thinking of adding telemedicine to your practice, here are the benefits—and things to consider.
Thanks to technology, it may be possible to diagnose epilepsy in patients earlier and via noninvasive means.
A host of neuropsychiatric disorders are intrinsic to Parkinson disease or occur as a complication of the dopaminergic therapies. Here's what to look for.
What are the risks of anti-seizure meds in pregnancy? Benefits?
Here: 3 questions that challenge your acumen about the latest AAN guidelines on sudden unexplained death in epilepsy.
New studies shed light on topics such as nonencephalic pain and headache chronicity; benign childhood epilepsy with centrotemporal spikes and social cognition; and causal triggers of Alzheimer disease onset.
Adherence is a major concern for clinicians across all disciplines. Even the most effective treatment will not be successful if the patients does not adhere to the prescribed treatment strategy. Inside learn more about the problem and ways to maximize adherence.
Jobs associated with higher economic status appear to be risk factors for these neurologic disorders.
Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.
Alzheimer disease is not an equal opportunity employer. Insights about early life stressors and economic disadvantage.
What do the new AAN guidelines on SUDEP offer? Here’s a quick overview of the key facts.
The author discusses MG disease classifications as well as treatment goals and treatment adherence.